2 Dividend Stocks to Buy and Hold Through 2023 and Beyond
In today's volatile market and challenging economy, dividend stocks may be just what many investors need. Dividends can be a source of passive income -- something that could come in handy with nearly 40-year-high inflation -- and help smooth out market losses.
That said, not all dividend-paying companies are created equal, and it is essential to pick those unlikely to reduce or cancel their payouts even amid economic troubles. Let's look at two excellent dividend stocks that fit the bill: Merck (NYSE: MRK) and Bristol Myers Squibb (NYSE: BMY).
Merck is one of the largest pharmaceutical companies in the world with an impressive portfolio of medicines, none more famous than cancer therapy Keytruda. The drugmaker has earned dozen of indications for its crown jewel with no end in sight. Keytruda accounts for a decent share of Merck's total revenue; it is also its fastest-growing product in terms of sales.
Source Fool.com
